Literature DB >> 1906911

Variation in class 5 protein expression by serogroup A meningococci during a meningitis epidemic.

M Achtman1, R A Wall, M Bopp, B Kusecek, G Morelli, E Saken, M Hassan-King.   

Abstract

Serogroup A meningococci were isolated from patients and healthy carriers in The Gambia between 1982 and 1988. The class 5 proteins expressed by these bacteria were identified by electrophoretic migration and by serologic tests. Three protein serologic groupings (seroclasses) called A (protein 5a), B (proteins 5b, 5d, or 5e), and C (protein 5c or 5C) were found among 331 bacterial isolates. The number of class 5 proteins expressed per isolate varied from none to four, with a median of two. The class 5 protein composition differed for certain paired isolates obtained from the nasopharynx, blood, and cerebrospinal fluid of diseased patients and for certain pairs of sequential isolates from the nasopharynx of healthy carriers; the medical relevance of this variation remains unclear, although the 5C protein was preferentially isolated from the nasopharynx and the 5a protein from diseased patients. The data show that a large proportion of healthy carriers in The Gambia were exposed to bacteria expressing each of the three seroclasses and that many people were exposed to bacteria expressing each of the three seroclasses and that many people were exposed to two or all three seroclasses during the epidemic of 1982-1983.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906911     DOI: 10.1093/infdis/164.2.375

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates.

Authors:  Jeannette N Williams; Paul J Skipp; C David O'Connor; Myron Christodoulides; John E Heckels
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

2.  Surface antigen analysis of group B Neisseria meningitis outer membrane by monoclonal antibodies: identification of bactericidal antibodies to class 5 protein.

Authors:  M G Danelli; N M Batoreu; M D Lacerda; C R Ferreira; J D Cardoso; J M Peralta; C E Frasch
Journal:  Curr Microbiol       Date:  1995-09       Impact factor: 2.188

3.  The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of the two mapped strains of the closely related species N. gonorrhoeae.

Authors:  J A Dempsey; A B Wallace; J G Cannon
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

4.  Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex.

Authors:  B Rokbi; M Mignon; D A Caugant; M J Quentin-Millet
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  A tissue culture bilayer model to study the passage of Neisseria meningitidis.

Authors:  K A Birkness; B L Swisher; E H White; E G Long; E P Ewing; F D Quinn
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

7.  Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species.

Authors:  Agnès Perrin; Stéphane Bonacorsi; Etienne Carbonnelle; Driss Talibi; Philippe Dessen; Xavier Nassif; Colin Tinsley
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: two closely related bacteria expressing two different pathogenicities.

Authors:  C R Tinsley; X Nassif
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

9.  Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype.

Authors:  Christopher D Bayliss; J Claire Hoe; Katherine Makepeace; Patricia Martin; Derek W Hood; E Richard Moxon
Journal:  Infect Immun       Date:  2008-08-11       Impact factor: 3.441

10.  Identification of neisserial DNA binding components.

Authors:  Emma Lång; Kristine Haugen; Burkhard Fleckenstein; Håvard Homberset; Stephan A Frye; Ole Herman Ambur; Tone Tønjum
Journal:  Microbiology (Reading)       Date:  2009-03       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.